Treatment of Blepharitis
Begin with daily warm compresses and eyelid hygiene as first-line therapy for all types of blepharitis, then escalate to topical antibiotics (bacitracin or erythromycin ointment) if inadequate response after 2-4 weeks, and reserve oral antibiotics (doxycycline or tetracyclines) for severe posterior blepharitis/meibomian gland dysfunction unresponsive to conservative measures. 1, 2
Understanding the Disease
Blepharitis is classified into two anatomical types that guide treatment selection 1:
- Anterior blepharitis: Affects the eyelid skin, base of eyelashes, and follicles, typically bacterial (staphylococcal) or seborrheic in nature 1
- Posterior blepharitis (Meibomian Gland Dysfunction/MGD): Affects the meibomian glands with obstruction and abnormal secretions 1
Critical caveat: Blepharitis is typically chronic and cannot be permanently cured; symptoms recur when treatment is discontinued, so patients must understand this requires ongoing long-term management rather than expecting complete resolution 3, 1, 2
First-Line Treatment Algorithm
Step 1: Eyelid Hygiene (All Patients)
- Apply for several minutes once or twice daily to soften crusts and warm meibomian secretions 3, 1
- Warning: Ensure compresses are not too hot to prevent skin burns 1
- Patients with advanced glaucoma should avoid aggressive lid pressure as it may increase intraocular pressure 3
- Gently rub the base of eyelashes using diluted baby shampoo or commercially available eyelid cleaner on a pad, cotton ball, or clean fingertip 3
- Hypochlorous acid 0.01% eye cleaners have strong antimicrobial effects for both anterior and posterior blepharitis 1, 2
- For anterior blepharitis, carefully remove all scales and crusts before applying treatment 4
- Continue daily or several times weekly long-term to control chronic symptoms 3
Meibomian gland expression (for posterior blepharitis/MGD) 3, 1:
- Perform vertical eyelid massage to express meibomian secretions 1
- Must be done with care to avoid mechanically induced irritation 3
Artificial tears 1:
- Use to manage associated dry eye symptoms, especially oil or lipid-containing products 1
Step 2: Topical Antibiotics (If Inadequate Response After 2-4 Weeks)
For anterior blepharitis 3, 2, 4:
- Bacitracin or erythromycin ointment applied to eyelid margins one or more times daily or at bedtime for a few weeks 3, 2
- FDA-approved dosing for bacitracin: Apply directly into the conjunctival sac 1 to 3 times daily, spreading uniformly over lid margins after removing scales and crusts 4
- Topical antibiotics decrease bacterial load and provide symptomatic relief 3, 2
Important practice point: Rotate different antibiotic medications intermittently with different mechanisms of action to prevent development of resistant organisms 3, 2
Alternative topical options (off-label, manufacturer-sponsored studies) 3:
- Azithromycin in sustained release system has shown efficacy in reducing signs and symptoms 3, 1
- Tobramycin/dexamethasone suspension may reduce signs and symptoms 3
Step 3: Oral Antibiotics (For Severe/Persistent Posterior Blepharitis/MGD)
When chronic symptoms and signs are not adequately controlled by eyelid cleansing or meibomian gland expression 3, 2:
- Doxycycline, minocycline, or tetracycline given daily, then tapered after clinical improvement 3, 2
- Doxycycline is the standard regimen for severe cases 1
- Sustained-release doxycycline preparation can reduce side effects 3
- Mechanism: Tetracyclines decrease lipase production in S. epidermidis and S. aureus, and have anti-inflammatory activity 3
Women of childbearing age and children 3, 2:
- Erythromycin or azithromycin as alternatives 3, 2
- Azithromycin oral pulse regimen: 1 g per week for 3 weeks 1
- Contraindication: Tetracyclines should not be used in children under 8 years (tooth staining), pregnancy, or nursing women 3
- Can cause photosensitization, gastrointestinal upset, vaginitis, rarely azotemia 3
- Implicated in pseudotumor cerebri cases 3
- May decrease effectiveness of oral contraceptives and potentiate warfarin effect 3
- Azithromycin may cause cardiac rhythm abnormalities, especially in patients with high baseline cardiovascular risk 1
Treatment pattern: Can be intermittently discontinued and reinstated based on severity and medication tolerance 3
Adjunctive Therapies
Short-Term Anti-Inflammatory Treatment
- Consider for eyelid or ocular surface inflammation, including marginal keratitis or phlyctenules 1
- Use for limited duration (1-2 weeks) to minimize steroid-related complications 2
- Safer options: Loteprednol etabonate and fluorometholone phosphate due to site-specific action and limited ocular penetration 1
- Corticosteroid-antibiotic combinations may be effective but evidence is inconclusive 3, 2
Additional Options for Refractory Cases
Cyclosporine topical 1:
- May be useful in some patients with posterior blepharitis and coexisting aqueous tear deficiency 1
Perfluorohexyloctane 1:
- Can prevent tear evaporation and improve symptoms in patients with associated dry eye disease 1
Omega-3 fatty acid supplements 1:
- Mixed evidence; some studies show improvement in tear break-up time, dry eye symptoms, and meibum score 1
Tea tree oil 1:
- 50% concentration can be considered for Demodex treatment in patients who do not improve with previous treatments 1
In-office procedures 1:
- Vectored thermal pulsation or microblepharoexfoliation may be considered for recalcitrant cases 1
Special Considerations
- Address moderate to severe blepharitis prior to intraocular surgery to reduce risk of postoperative endophthalmitis 2
- Consider antibiotics like ofloxacin when preparing for intraocular surgery 1
Patient dexterity concerns 3:
- Eyelid cleaning and digital massage can be dangerous if patient lacks manual dexterity, skill, or judgment 3
- Tailor therapeutic plan to patient's ability to perform treatment safely 3
Neurotrophic corneas 3:
- Proper counseling is important to avoid injury to corneal epithelium during eyelid hygiene 3
Evidence Quality Note
A Cochrane systematic review reported uncertainty regarding effectiveness of both topical and systemic treatments for blepharokeratoconjunctivitis in children due to lack of high-quality evidence, highlighting the need for individualized clinical judgment in pediatric cases 2